Cargando…
Advances in lung cancer
Autores principales: | Pacheco, Jose M., Dimou, Anastasios, Bunn, Paul A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667952/ https://www.ncbi.nlm.nih.gov/pubmed/29108218 http://dx.doi.org/10.18632/oncotarget.20854 |
Ejemplares similares
-
Optimal Therapy for Advanced Non-Small Cell Lung Cancer Without Driver Alterations
por: Pacheco, Jose, et al.
Publicado: (2021) -
Cecal Volvulus as a Rare Complication of Osimertinib Dosed at 160 mg in Patients With EGFR-Mutant Non-small Cell Lung Cancer
por: Patil, Tejas, et al.
Publicado: (2020) -
Changing paradigm in advanced and metastatic non-small cell lung cancer
por: Uprety, Dipesh, et al.
Publicado: (2020) -
Non-Small Cell Lung Cancer beyond Biomarkers: The Evolving Landscape of Clinical Trial Design
por: Dimou, Anastasios, et al.
Publicado: (2014) -
From the Bench to Bedside: Biological and Methodology Considerations for the Future of Companion Diagnostics in Nonsmall Cell Lung Cancer
por: Dimou, Anastasios, et al.
Publicado: (2011)